Heart disease drug can make users less racially biased

.

Heart disease drug can make users less racially biased

A commonly used heart drug can make the user less racially biased by altering their subconscious racial attitudes, researchers at Oxford University found in a study.

Propranolol, the heart drug that acts on nerve circuits and the part of the brain that involves in fear & emotional responses, was found very helpful altering their subconscious racial attitudes.

The researchers said that racism is founded on fear and the drug damp down fear by blocking nerve circuits that control the heart rate and the brain-part linked with fear & emotional responses.

Two groups of 18 volunteers participated in the study. Each volunteer was asked to take a "racial Implicit Association Test" 1-2 hours after taking propranolol or the `dummy' placebo drug.

Those who had taken propranolol scored lower on the psychological test of "implicit" racist attitudes than others who were given the "dummy" placebo pills.

Professor Julian Savulescu, who co-authored the study, said, "The scientists wrote: "The main finding of our study is that propranolol significantly reduced implicit but not explicit racial bias."

But, Professor Savulescu clarified that propranolol is not a cure to treat racism as it can not reduce explicit racial bias.


Latest News

Report Shows Large Number of Americans still Prefer Receiving Credit Card Statem
U.S. Big Banks Pass Annual Stress Test
Viacom’s Board will Remain as it is for the Time being, Judge Sets Hearing for J
Crude Stockpiles Drop in the U. S
A New Study Highlights that U. S. Expected to Spend $2.6 Trillion Less than Esti
SolarCity Shares Soar with Tesla's Bid for the Company
The Leave as well as Remain Camps Gathers Pace in Brexit
Oil’s Advance Halts as Market Awaits U.S Stock Pile Data and Brexit Poll
Martin Winterkorn and a Current VW Board Member Under Investigation by Prosecuto
Survey Shows Some Workplace Benefits are Fading with Time
Kimco Realty Corporation Shares Climbed 0.21 Percent Last Week
Sluggish Growth and Inflation is Taking More Time Than Expected Affecting Fed’s